Desmond N. Carney

Desmond N. Carney's AcademicInfluence.com Rankings

Desmond N. Carney

Chemistry

#2736

World Rank

#3686

Historical Rank

chemistry Degrees

Desmond N. Carney

Biology

#7718

World Rank

#10680

Historical Rank

Cell Biology

#288

World Rank

#296

Historical Rank

Molecular Biology

#914

World Rank

#937

Historical Rank

Biochemistry

#1071

World Rank

#1186

Historical Rank

biology Degrees

Download Badge

Chemistry
Biology

Desmond N. Carney's Degrees

PhD Biochemistry University of California, San Francisco
Bachelors Chemistry Stanford University

Why Is Desmond N. Carney Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Desmond N. Carney's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer (1985) (1359)
Establishment and identification of small cell lung cancer cell lines having classic and variant features. (1985) (948)
Amplification and expression of the c-myc oncogene in human lung cancer cell lines (1983) (914)
Taxanes, microtubules and chemoresistant breast cancer. (2008) (534)
High levels of intracellular bombesin characterize human small-cell lung carcinoma. (1981) (485)
Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. (1985) (476)
Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). (1982) (465)
The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer (2009) (440)
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer (2007) (411)
Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. (1980) (407)
Chemotherapy induced nausea and vomiting. (1994) (382)
SERUM NEURON-SPECIFIC ENOLASE: A MARKER FOR DISEASE EXTENT AND RESPONSE TO THERAPY OF SMALL-CELL LUNG CANCER (1982) (379)
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer (1985) (355)
Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. (1980) (351)
A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). (1982) (321)
NCI‐navy medical oncology branch cell line data base (1996) (306)
Human small-cell lung cancers show amplification and expression of the N-myc gene. (1986) (300)
Lung cancer--time to move on from chemotherapy. (2002) (290)
In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. (1983) (285)
Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide (1987) (271)
Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. (1986) (269)
High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer. (1985) (248)
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. (1987) (236)
Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung. (1981) (209)
Small cell lung cancer 1973-1983: early progress and recent obstacles. (1984) (208)
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy (1991) (200)
Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. (1991) (200)
The clinical behavior of „mixed”︁ small cell/large cell bronchogenic carcinoma compared to „pure”︁ small cell subtypes (1982) (187)
Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. (1983) (173)
Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells. (1985) (168)
Single-agent oral etoposide for elderly small cell lung cancer patients. (1990) (158)
Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores. (1989) (158)
c‐erbB‐2 oncoprotein expression in primary human tumors (1990) (158)
Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. (1981) (148)
Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture. (1980) (133)
Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. (1986) (132)
Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. (1995) (132)
Prognostic significance of microvessel density in lymph node negative breast carcinoma. (1995) (125)
Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. (1995) (122)
Positive correlation between histological tumor involvement and generation of tumor cell colonies in agarose in specimens taken directly from patients with small-cell carcinoma of the lung. (1980) (119)
Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. (1982) (116)
Imaging of primary non-Hodgkin's lymphoma of the liver. (2001) (114)
Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. (1981) (114)
Bombesin-like peptides and receptors in human tumor cell lines (1983) (113)
Secretin/vasoactive intestinal peptide-stimulated secretion of bombesin/gastrin releasing peptide from human small cell carcinoma of the lung. (1986) (112)
Low‐grade fibromyxoid sarcoma (1990) (112)
Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. (1986) (109)
Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. (1983) (106)
Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. (1989) (103)
A comparison of whole-body MRI and CT for the staging of lymphoma. (2005) (102)
Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. (1983) (102)
Neuron specific enolase in human small cell carcinoma cultures. (1982) (102)
DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. (1980) (96)
Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. (1992) (87)
A phase II study of oral etoposide in elderly patients with small cell lung cancer. (1989) (87)
Elevated serum creatine kinase BB levels in patients with small cell lung cancer. (1984) (85)
Cell culture methods for the establishment of the NCI series of lung cancer cell lines (1996) (83)
A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. (1995) (78)
Non-small-cell lung cancer--stalemate or progress? (2000) (76)
Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy, and survival. (1980) (76)
Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies. (1984) (74)
Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. (1986) (73)
Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier. (1985) (72)
Small-cell carcinoma of lung: reinduction therapy after late relapse. (1983) (69)
Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results. (1993) (65)
Amplification, expression and rearrangement of c-myc and N-myc oncogenes in human lung cancer. (1984) (65)
Differential expression of intermediate filament proteins distinguishes classic from variant small-cell lung cancer cell lines. (1985) (65)
Overview of chemotherapy for small cell lung cancer. (1997) (64)
Neurotensin is produced by and secreted from classic small cell lung cancer cells. (1985) (63)
Experimental studies of the biology of human small cell lung cancer. (1983) (62)
Heterogeneity in the radiation survival curves and biochemical properties of human lung cancer cell lines. (1984) (61)
Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. (1986) (58)
The biology of non-small cell lung cancer. (1983) (57)
Somatostatin, Its Receptors and Analogs, in Lung Cancer (2001) (56)
Autocrine growth factors in human small cell lung cancer. (1985) (55)
Biological heterogeneity of small cell lung cancer. (1985) (55)
Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy. (1983) (50)
Osteosarcoma: use of MR imaging and MR spectroscopy in clinical decision making. (1989) (48)
The role of radiation therapy in the treatment of small cell lung cancer (1985) (48)
31P MRS as an early prognostic indicator of patient response to chemotherapy (1992) (46)
High affinity binding of VIP to human lung cancer cell lines (1987) (45)
Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate. (1985) (44)
Heterotransplantation of small‐cell carcinoma of the lung into nude mice: Comparison of intracranial and subcutaneous routes (1981) (44)
The pharmacology of intravenous and oral etoposide (1991) (42)
Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells. (1985) (42)
Antiangiogenic therapy in lung cancer: focus on vascular endothelial growth factor pathway (2010) (41)
Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue. (1994) (41)
Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimens. (1994) (40)
Continuous culture and soft agarose cloning of multiple human breast carcinoma cell lines in serum-free medium. (1984) (40)
Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p. (1987) (40)
Somatostatin receptor expression in lung cancer. (1994) (40)
Bacteremia due to Staphylococcus aureus in patients with cancer: report on 45 cases in adults and review of the literature. (1982) (38)
Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates. (1986) (38)
Lung cancer biology. (1988) (37)
Chemotherapy in the management of patients with inoperable non-small cell lung cancer. (1996) (37)
Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review (2015) (35)
Neurotensin binds with high affinity to small cell lung cancer cells (1988) (35)
The detection of specific gene rearrangements in non-Hodgkin's lymphoma using the polymerase chain reaction. (1992) (34)
Expression of peptide and other markers in lung cancer cell lines. (1985) (33)
Predictive testing for BRCA1 and 2 mutations: a male contribution. (2003) (33)
Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress? (2011) (32)
Evidence for multidrug-resistant cells in human tumor cell populations. (1983) (32)
Somatostatin and the lung. (1993) (32)
Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. (1986) (31)
Primary bone lymphoma: single institution case series (2008) (31)
Diagnosis and significance of liver metastases in small cell carcinoma of the lung. (1984) (31)
Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes. (1994) (30)
Biology of small-cell lung cancer (1992) (29)
In vitro growth inhibition of human small cell lung cancer by physalaemin. (1987) (27)
Molecular and Clinical Aspects of Targeting the VEGF Pathway in Tumors (2010) (27)
Small cell cancer of the lung. (1982) (27)
Epidermal growth factor receptor-targeted agents for lung cancer. (2006) (26)
Mycosis fungoides bullosa simulating pyoderma gangrenosum (2000) (26)
Radiolabelled somatostatin analogue scintigraphy in oncology (1996) (26)
Prophylactic cranial irradiation and small-cell lung cancer. (1999) (26)
Small cell lung cancer in the elderly. (1994) (25)
Intratubular germ cell neoplasia of the testis: identification by placental alkaline phosphatase immunostaining and argyrophilic nucleolar organizer region quantification. (1990) (24)
Tissue characterization and assessment of preoperative chemotherapeutic response in musculoskeletal tumors by in vivo 31p magnetic resonance spectroscopy (1992) (23)
Manifestations of cutaneous T-cell lymphoma. (1980) (23)
Angiosarcoma arising from a defunctionalized arteriovenous fistula. (1993) (23)
Small-cell carcinoma of the cervix at 23 weeks gestation. (2010) (21)
In vitro growth of cutaneous T-cell lymphomas. (1979) (21)
Aberrant MT2 positivity distinguishes follicular lymphoma from reactive follicular hyperplasia in B5- and formalin-fixed paraffin sections. (1991) (20)
Immunohistology of lung cancer. (1989) (20)
Calcitonin secretion by continuous cultures of small cell carcinoma of the lung: incidence and immunoheterogeneity studies. (1983) (20)
Suppression of malignancy in human lung cancer (A549/8) times mouse fibroblast (3T3-4E) somatic cell hybrids. (1979) (19)
Experience of the National Cancer Institute (USA) in the treatment and biology of small cell lung cancer. (1982) (18)
The serum-free establishment and in vitro growth properties of classic and variant small cell lung cancer cell lines. (1985) (18)
The diagnostic value of silver nucleolar organizer region assessment in breast cytology. (1994) (18)
c-erbB-2 oncoprotein expression in malignant and nonmalignant breast tissue (1989) (18)
Lymphocyte transformation in patients with cutaneous T‐cell lymphomas (1980) (17)
Imaging of bronchial carcinoid tumours with indium-111 pentetreotide. (1994) (17)
In vitro chemosensitivity of human lung cancer cell lines. (1987) (16)
Cancer in the elderly. (1993) (16)
New agents in the management of advanced non-small cell lung cancer. (1998) (16)
Case report: bilateral recurrent tension pneumothorax complicating combination chemotherapy for soft tissue sarcoma. (1996) (16)
Synthesis and retention of methotrexate polyglutamates by human small cell lung cancer. (1984) (16)
Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines. (1988) (15)
Combination chemotherapy with doxorubicin and mitomycin C in non small cell bronchogenic carcinoma: Severe pulmonary toxicity from q 3 weekly mitomycin C (1984) (15)
Fatal hypereosinophilia with chromosome 15q- in a patient with multiple primary and familial neoplasms. (1983) (15)
Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines. (1992) (15)
Acute vascular events associated with cisplatin therapy in malignant disease. (2002) (14)
Primary hepatic lymphoma in a man with chronic hepatitis C. (1997) (14)
The biology of lung cancer. A review. (1989) (14)
Neuron-specific enolase: how useful as a cancer marker? (1988) (14)
Recent advances in the biology of small cell lung cancer. (1986) (14)
Oral etoposide in small cell lung cancer. (1992) (14)
Levels of high energy phosphates in human lung cancer cell lines by 31P nuclear magnetic resonance spectroscopy. (1987) (13)
Carboplatin/etoposide combination chemotherapy in the treatment of poor prognosis patients with small cell lung cancer. (1995) (13)
Primary multifocal skeletal Hodgkin’s disease confined to bone (2006) (13)
BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL). (1997) (12)
Hormone supplemented media for cloning human breast cancer: increased colony formation without alteration of chemosensitivity. (1983) (12)
Two carboplatin-containing regimens for small cell lung cancer: preliminary results of a randomized phase II trial. (1988) (12)
Progressive multifocal leukoencephalopathy secondary to rituximab-induced immunosuppression and the presence of John Cunningham virus: a case report and literature review (2016) (11)
Quantitative description of classic and variant small cell lung cancer cell lines by nuclear image cytometry. (1988) (11)
Treatment of cutaneous T-cell lymphoma. (1980) (11)
Lung cancer biology. (1991) (11)
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group. (1992) (10)
Management (chemotherapy/best supportive care) of advanced-stage non-small cell lung cancer. (1995) (10)
Treatment of elderly patients with small cell lung cancer (1993) (10)
In vitro assays of chemotherapeutic sensitivity. (1985) (10)
Merkel cell carcinoma metastasis to the iris in a 23 year old female. (2009) (10)
Virtual oncology clinics during the COVID-19 pandemic (2021) (10)
Small cell carcinoma of the lung: altered morphological, bio- logical and biochemical characteristics in long term cultures and heterotransplanted tumors. Abstr. (1980) (9)
Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung. (1982) (9)
Bombesin: A Potent Mitogen for Small Cell Lung Cancer (1988) (9)
Post irradiation olfactory neuroblastoma (esthesioneuroblastoma): A case report and up to date review (2009) (9)
Biochemical markers of lung cancer (1988) (9)
BN/GRP-like peptides and receptors in small cell lung cancer. (1988) (9)
Oncogenes and genetic abnormalities in lung cancer. (1989) (8)
Clinical implications of the biology of small cell lung cancer. (1987) (8)
In Vitro Study of the Biology of Small Cell Carcinoma of the Lung (1981) (8)
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung (1983) (8)
A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung. (1982) (8)
Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice (2004) (8)
Extrarenal malignancy and the nephrotic syndrome. (1975) (8)
The biology of lung cancer (1992) (7)
Desmosomal plaque proteins are preserved in all grades of breast cancer. An immunohistochemical study utilizing monoclonal antibodies to desmoplakin. (1988) (7)
Imaging of small cell carcinoma of the oesophagus. (1995) (7)
Hypertensison is a significant adverse effect of bevacizumab treatment (2007) (7)
Molecular biology of lung cancer. (1998) (6)
Lung cancer biology. (1991) (6)
Non-M CK--a practical measure of creatine kinase isoenzymes in cancer patients. (1990) (6)
miR-433 overexpression attenuates the spindle assembly checkpoint response to paclitaxel (2010) (6)
Thyroid lymphoma: A single institution's experience (2007) (6)
Phase II study of carboplatin and cyclophosphamide combination chemotherapy for the treatment of advanced ovarian cancer. (1990) (6)
In vitro chemosensitivity of clinical specimens (CS) and established cell lines (CL) of small cell lung cancer (SCLC) (1981) (5)
The In Vitro Growth and Characterization of Small Cell Lung Cancer (1983) (5)
Argyrophylic nucleolar organiser regions (AgNOR’s) as a prognostic indicator in breast carcinoma (1992) (5)
Small cell lung cancer cell lines: pure and variant types can be distinguished by their extracellular matrix synthesis. (1988) (5)
Etoposide in the treatment of elderly/poor-prognosis patients with small-cell lung cancer (2004) (5)
The biology of lung cancer. (1995) (5)
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness. (1984) (5)
Treatment of advanced non‐small cell lung cancer with very high‐dose cisplatin combined with etoposide and mitomycin C (1993) (4)
Karyotypic derivation of H9 cell line. (1993) (4)
Aortic dissection presenting as superior vena cava obstruction (1991) (4)
The use of human lung cancer cell lines for in vitro chemosensitivity testing (1985) (4)
Osteosarcoma and second malignant neoplasms: a case series (2019) (4)
Scintigraphic imaging of lung tumours with a radiolabelled somatostatin analogue (1993) (4)
High‐dose methotrexate with leucovorin rescue in patients with unresectable non‐small cell carcinoma of the lung (1983) (4)
Carboplatin/cyclophosphamide combination chemotherapy for advanced ovarian cancer. (1992) (4)
The use of complementary and alternative medicine (CAM) by Irish patients with breast cancer. (2011) (3)
A non-random chromosomal abnormality del(3) (pl4-23) in small cell lung cancer (SCLC) (1983) (3)
The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer (1989) (3)
Elevation of true creatine kinase-MB in a patient with small-cell lung cancer. (1988) (3)
Immunohistochemical analysis of breast cancer oestrogen receptor status and its correlation with oestrogen receptor biochemical assay (1988) (3)
Resolution of small cell lung cancer intracranial metastases with standard dose chemotherapy (1989) (3)
Is chemotherapy always required for cancer in pregnancy? An observational study (2017) (3)
Human Lung Cancer Cell Lines Have Vasoactive Intestinal Peptide Receptors a (1988) (3)
Growth factors for lung cancer (1989) (3)
Monoclonal antibodies in lung cancer pathology. (1987) (2)
Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer (2004) (2)
The use of experimental systems in the therapeutic research of small cell lung cancer. (1982) (2)
A Multicenter Retrospective Review of Systemic Anti-Cancer Treatment and Palliative Care Provided to Solid Tumor Oncology Patients in the 12 Weeks Preceding Death in Ireland (2021) (2)
Methods for production of monoclonal antibodies with specificity for human lung cancer cells (1981) (2)
Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy. (2016) (2)
Inhibition of DNA synthesis by a small-cell lung carcinoma-derived protein. (1986) (2)
Non-small cell lung cancer: slow but definite progress. (1996) (2)
Non–Hodgkin’s Lymphoma of the Appendix (2015) (2)
Genes and cancer (1990) (2)
Levels of oxidative stress and telomeres in Lynch syndrome-associated malignancies. (2016) (1)
Biological response modifiers in the management of small cell lung cancer: a consensus report (1989) (1)
Clinical correlation of tumor endocrine markers in lung cancer. (1989) (1)
Small Cell Lung Cancer Cell Line Derived from a Primary Tumor with a Characteristic Deletion of 3p1 (2006) (1)
Peptides and Their Receptors in Oat Cell Carcinoma (1986) (1)
The Biologic Basis of Cancer Chemotherapy (1989) (1)
National Scientific Medical Meeting 1994 Abstracts (1994) (1)
Clinical Applications of the Biologic Properties of Small Cell Lung Cancer (1986) (1)
Soft tissue and visceral sarcomas in Irish patients (1994) (1)
Paclitaxel and Radiotherapy:The European Experience in Non–Small-Cell Lung Cancer (1999) (1)
Burkitt's lymphoma in a patient previously treated for Hodgkin's disease. (1989) (1)
FC132 Mycosis fungoides bullosa simulating pyoderma gangrenosum (1997) (1)
IMMUNOTHERAPY IN THE ELDERLY: AN IRISH STUDY (2019) (1)
Exome sequencing of metastatic medullary thyroid cancer. (2016) (1)
Clinical Correlates of Biological Studies of Small Cell Lung Cancer (1986) (1)
The use of complementary and alternative medicine (CAM) by Irish patients with cancer. (2011) (1)
Influence of growth factors and hormones on soft agarose cloning and in vitro drug sensitivity of human breast carcinoma cells (1982) (1)
An unusual case of dyspnea in metastatic breast carcinoma. (2011) (1)
Review of neoplastic brachial plexopathy at the Mater Misericordiae University Hospital, Ireland. (2009) (1)
Monoclonal Antibodies Against Human Lung Cancer: Potential Diagnostic and Therapeutic Use (1983) (1)
Benign and malignant monoclonal gammopathies. (1980) (1)
Complete radiological response of metastatic anaplastic lymphoma kinase-positive signet ring lung adenocarcinoma to systemic chemotherapy. (2011) (1)
The role of intensive care in the changing paradigm of modern cancer care. (2012) (0)
Clinical staging of small cell lung cancer: report of the International Association for the Study of Lung Cancer Staging Initiative, Small Cell Lung Cancer Subcommittee: E05-06 (2007) (0)
Abstract P4-22-23: Phase II trial of selinexor for metastatic triple negative breast cancer (2017) (0)
Irish association for cancer research Proceedings of 23rd Annual Meeting held in Cork, May, 1966 (1987) (0)
A multicentre survey of serum calcium levels in patients with malignant diseases. (1992) (0)
Royal Academy of Medicine in Ireland section of medicine (1994) (0)
Study to assess satisfaction of general practitioners (GP) with oncology services, GP awareness of follow-up guidelines for patients with cancer, and GP access to oncology services. (2011) (0)
Contemporary multi-modal management of colorectal cancer: Evolving patterns of care in an Irish cohort. (2018) (0)
P84.19 A Review of Clinical Outcomes of Irish Patients With ALK Rearranged NSCLC (2021) (0)
Metastatic renal cell carcinoma in the elderly: A single Irish institution experience. (2018) (0)
Abstract P6-08-17: Pregnancy associated breast cancer: Evaluating maternal outcomes. A multicentre study (2018) (0)
Royal academy of medicine in Ireland section of medicine (1990) (0)
A Single Centre Retrospective Analysis of Toxicity, Prognostication and Oncological Outcomes in Clinical Stage One Seminoma Treated with Carboplatin (2016) (0)
Aphase IIstudy oforal etoposide inelderly patients withsmall cell lung cancer (2011) (0)
8th Meeting of the Irish Society of Human Genetics, Monday 19th September 2005 (2006) (0)
Abdominal computed tomography in patients with small cell lung cancer (1988) (0)
Programmed death (PD)-1 inhibitors for advanced non-small cell lung cancer (NSCLC) in Ireland: a single centre experience (2018) (0)
Long term follow-up of primary B and T cell non-Hodgkin's lymphoma (NHL) of the gastrointestinal (GI) tract. (2009) (0)
Irish association for cancer research (1991) (0)
Irish association for cancer research (1994) (0)
Irish association for cancer research (1994) (0)
[Treatment of pulmonary non-small-cell cancer--stagnation or progress?]. (2001) (0)
Shortened telomere length to predict initiation of carcinogenesis in Lynch syndrome. (2014) (0)
Neoadjuvant chemotherapy for adult osteosarcoma: Results of long term follow-up (2008) (0)
Cell surface protein phenotype delineates the lineage of cultured human variant small cell lung cancer (SCCL-V) (1985) (0)
Discussion: Lung cancer (1996) (0)
Lung cancer: progress in diagnosis and treatment. (1984) (0)
;MALL CELL LUNG CANCER CLONAL GROWTH BY BOMBESIN AND GASTR (2002) (0)
The medical management of prostate carcinoma. (1993) (0)
606 Total enolase: A potential tumour marker in lung cancer (1997) (0)
Fourth Conference on Human Tumor Cloningl: (Tucson, Arizona, USA; January 8–10, 1984) (1984) (0)
Use of complementary and alternative medicine by older cancer patients (2013) (0)
Royal Academy of Medicine in Ireland Section of Biological Sciences Proceedings of Winter Meeting held on Monday, 5th January, 1987 (1987) (0)
Switching chemotherapy in adult osteosarcoma patients with poor necrosis rates post neoadjuvant methotrexate, cisplatin, and doxorubicin (MAP). (2013) (0)
Molecular biology of cancer. (1990) (0)
Extrarenal malignancy andthenephrotic syndrome (1975) (0)
Irish Society of Gastroenterology — Winter Meeting Held at Freeman Auditorium, Mater Misericordiae Hospital, Dublin on Friday, 20th and Saturday, 21st November, 1987 (1988) (0)
Neglected breast cancers in an inner city hospital. (2015) (0)
Morphological Variants Cell Lines of Human Small Cell Lung Cancer and Its Large Cell Radiation and Chemotherapy Sensitivity of Established In Vitro Updated (2006) (0)
Significant response to carboplatin/pemetrexed chemotherapy in malignant pleural mesothelioma (2010) (0)
Abstract PS12-25: Patterns of treatment and outcomes in real world patients with advanced estrogen receptor positive breast cancer receiving palbociclib and endocrine therapy (2021) (0)
Abstract 2028: miR-433 attenuates the spindle assembly checkpoint (SAC) response to paclitaxel (2010) (0)
Cancer in pregnancy: To treat or not? (2013) (0)
Suppression of murine immunologic functions by fresh and cultured human tumor extracts. (1985) (0)
Differential Nephrotoxicity of Cisplatin and Carboplatin (1986) (0)
Irish Association for Cancer Research (1995) (0)
Small cell carcinoma of the cervix. (2010) (0)
Irish Association for Cancer Research (1995) (0)
University of Groningen Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines (2005) (0)
Erdheim-Chester disease diagnosed by renal biopsy (2016) (0)
European Organization for Research and Treatment of Cancer Workshop Problems and Prospects in Current Therapeutic Application of Molecular Biology1 (1987) (0)
Drugs for the Treatment of Respiratory Diseases: Small cell lung cancer (2003) (0)
Ovarian carcinoma. (1989) (0)
Irish association for cancer research (1991) (0)
Inaugural national scientific medical meeting (1993) (0)
Lack of association of telomerase expression levels with telomere length variation in Lynch syndrome patients. (2015) (0)
Positive Correlation between Histological Tumor Involvement and Generationof Tumor Cell ColOniesin Agarose in SpecimensTaken Directly from Patients with Small-Cell Carcinoma of the Lung (2006) (0)
Bombesin/Gastrin-Releasing Peptide Stimulation of Small-Cell Lung Cancer Clonal Growth (1986) (0)
The biology of lung cancer. (1992) (0)
Pregnancy following surgery and chemotherapy for ovarian germ cell tumors. (2013) (0)
Primary bone lymphoma: Single institution experience (2008) (0)
Therapeutic challenges: Cancer and pregnancy. (2010) (0)
Primary lymphoma of the inferior oblique muscle (1989) (0)
Lung cancer in the young: an Irish case series (2019) (0)
Staphylococcal Bacteremia in Cancer Patients: Intravenous and Oral Antimicrobial Therapy (1982) (0)
Invited editorial: Molecular biology of cancer (1990) (0)
Royal academy of medicine in Ireland section of pathology (1992) (0)
Intensive Care as a Key Player in the Changing Paradigm of Modern Cancer Care: A Single Institution Experience (2012) (0)

This paper list is powered by the following services:

Desmond N. Carney's Academic­Influence.com Rankings

Desmond N. Carney's Degrees

Why Is Desmond N. Carney Influential?

Desmond N. Carney's Published Works

Published Works

Desmond N. Carney's AcademicInfluence.com Rankings